Today: 8 February 2026
Subscribe
Browse Category

NYSE:MDT News 28 June 2025 - 30 January 2026

Boston Scientific stock snaps a 4-day run — what to watch before Feb. 4 earnings

Boston Scientific stock snaps a 4-day run — what to watch before Feb. 4 earnings

Boston Scientific shares fell 1.6% to $92.33 Thursday, ending a four-day rally on heavy volume after the company completed its acquisition of Nalu Medical. The stock underperformed sector peers as investors awaited fourth-quarter results due Feb. 4 and looked for updates on recent deal activity, including the $14.5 billion Penumbra purchase.
30 January 2026
······
Medtronic (MDT) Stock Update: Dividend Timing, MiniMed IPO Catalyst, and What Investors Should Watch Before Monday’s Open

Medtronic (MDT) Stock Update: Dividend Timing, MiniMed IPO Catalyst, and What Investors Should Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 4:09 p.m. ET — Market closed. New York Stock Exchange Medtronic plc (NYSE: MDT) heads into the final full trading week of 2025 with U.S. equities closed for the weekend and futures reopening Sunday evening—setting the stage for Monday’s regular-session restart. The broader market backdrop remains constructive late in the year, with major indexes having pushed to record territory recently and investors still focused on “Santa rally” dynamics and year-end positioning. Investors+1 For Medtronic stock specifically, the most immediate investor questions are straightforward: where MDT finished the last session, what (if anything) hit the newswire
28 December 2025
·
Medtronic (MDT) Stock After Hours on Dec. 24, 2025: FDA Class I Recall Headline, Options Surge, Dividend Timing, and What to Watch Before Markets Reopen

Medtronic (MDT) Stock After Hours on Dec. 24, 2025: FDA Class I Recall Headline, Options Surge, Dividend Timing, and What to Watch Before Markets Reopen

Medtronic closed at $97.27 on Dec. 24, 2025, with light volume ahead of the Christmas holiday. After-hours trading showed a slight uptick to $97.45. The FDA classified Medtronic’s recall of certain DLP Left Heart Vent Catheters as Class I, citing risk of serious injury or death. Medtronic reported three serious injuries and no deaths linked to the issue.
25 December 2025
Intuitive Surgical (ISRG) stock: What to know before the U.S. market opens on Dec. 15, 2025

Intuitive Surgical (ISRG) stock: What to know before the U.S. market opens on Dec. 15, 2025

As U.S. markets head into Monday’s open (Dec. 15, 2025), Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus after a busy stretch of headlines spanning new FDA clearances, competitive pressure rising, and fresh Wall Street calls. Shares most recently traded around $542.32 (based on the latest available pricing ahead of Monday’s session). Below is what investors and watchlists are likely keying on before the opening bell. 1) The newest catalyst: FDA expands da Vinci SP indications (Dec. 10) Intuitive’s most recent company-driven headline is a new U.S. FDA clearance for its da Vinci Single Port (SP) system—expanding indicated use
14 December 2025
·
Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Updated: December 7, 2025 Key Takeaways 1. Medtronic (MDT) Stock Snapshot on December 7, 2025 As of the latest completed trading session (Dec. 5, 2025), Medtronic’s NYSE‑listed shares closed at $101.36, with modest after‑hours trading around $101.31. StockAnalysis Key stats at a glance: Trading over the last week has been choppy as markets digest macro headlines and rotations within healthcare. On Dec. 1, MDT fell about 1.9% to $103.34, underperforming the S&P 500 and Dow. A day later, it slipped another 1.3% to $102.03, leaving it around 4% below its recent 52‑week high of $106.33. MarketWatch+1 Even so, post‑earnings commentary
7 December 2025
·
Medtronic (MDT) Stock News Today: Hugo Robot FDA Clearance, Diabetes Spin-Off and Dividend Strength Shape 2026 Outlook

Medtronic (MDT) Stock News Today: Hugo Robot FDA Clearance, Diabetes Spin-Off and Dividend Strength Shape 2026 Outlook

As of the close on 5 December 2025, Medtronic plc (NYSE: MDT) stock trades around $101.36–$101.39 per share, giving the medical device giant a market capitalization of roughly $130 billion, a P/E ratio near 27.4, and a dividend yield of about 2.8%. MarketBeat+2StockAnalysis+2 In the first week of December, Medtronic has delivered a flurry of stock‑moving news: a new FDA clearance for its Hugo™ robotic-assisted surgery system, a U.S. launch of its next‑gen MiniMed™ 780G insulin pump with Abbott’s Instinct™ sensor, a fresh quarterly dividend declaration, and ongoing progress toward the spin‑off of its Diabetes business. At the same time,
6 December 2025
·
Medtronic (MDT) Stock Near 52‑Week High as Truist Hikes Target and Norges Bank Buys Big

Medtronic (MDT) Stock Near 52‑Week High as Truist Hikes Target and Norges Bank Buys Big

Medtronic plc (NYSE: MDT) is back in the spotlight on 29 November 2025, with its stock trading close to record levels after a strong earnings beat, a fresh wave of analyst updates and sizeable moves from some of the world’s biggest institutional investors. Below is a deep dive into what’s moving Medtronic stock today, and what it could mean for investors watching MDT on Google News and Discover. Snapshot: Where Medtronic Stock Stands Now As of the latest close on 28 November 2025, Medtronic shares trade around $105.33, giving the company a market capitalization of roughly $135 billion.Stock Titan+2Macrotrends+2 Key
30 November 2025
·
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Published: November 18, 2025 Medtronic plc (NYSE: MDT) is back in the spotlight today after reporting stronger‑than‑expected results for the second quarter of fiscal 2026 and raising its full‑year outlook. The medical technology giant delivered solid revenue and earnings growth, highlighted powerful momentum in its cardiac ablation franchise, and signaled confidence in accelerating growth in the second half of the year. Medtronic News+1 Shares of Medtronic jumped intraday to around $100–101, up roughly 4–5% after the announcement, as investors reacted to a classic “beat‑and‑raise” quarter. ChartMill Q2 FY26 by the numbers: solid beat on revenue and EPS For the quarter
18 November 2025
···
Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Industry & Corporate Developments Mergers, Acquisitions & Partnerships Regulatory & Drug Approval Updates Public Health & Policy Research & Clinical Breakthroughs Sources: Reuters, Politico, HealthLeaders, BioPharma Dive, FierceBiotech, Pharmaceutical Executive, Technology Networks, McGill University reuters.com reuters.com healthleadersmedia.com reuters.com fiercebiotech.com reuters.com reuters.com technologynetworks.com technologynetworks.com.
21 August 2025
······
Robotics and Automation Trends 2025: Industry Breakthroughs and Market Outlook (Updated: June 27th, 2025)

Robotics and Automation Trends 2025: Industry Breakthroughs and Market Outlook (Updated: June 27th, 2025)

In 2024 the value of new industrial robot installations reached $16.5 billion, with over 4.28 million robots operating in factories worldwide. Asia accounted for 70% of new robot installations in 2023, with China alone representing 51% of 2023 installations. In 2025 robotics is being transformed by AI, with analytical AI, Physical AI simulators like NVIDIA’s Omniverse and Isaac, and Generative AI driving a “ChatGPT moment” for physical robots. Humanoid robots like Tesla’s Optimus target about $20,000 per unit, with forecasts calling for about 40,000 units by 2032 and a $38–66 billion market by 2035. In 2024 Intuitive Surgical’s da Vinci
28 June 2025
········

Stock Market Today

Intel stock price jumps to $50: China CPU delays and SambaNova funding set up week ahead

Intel stock price jumps to $50: China CPU delays and SambaNova funding set up week ahead

8 February 2026
Intel shares rose 4.9% to $50.59 Friday, tracking a 5.7% jump in the PHLX semiconductor index as investors bet on AI-driven data-center spending. Reuters reported Intel and AMD warned Chinese customers of tighter server CPU supply, pushing Intel’s China prices up over 10%. Intel expects supply to improve in Q2. After the bell, Reuters said Intel plans to invest about $100 million in AI chip startup SambaNova Systems.
Go toTop